Proposal of a magnetic resonance imaging follow-up protocol after cholesteatoma surgery: a prospective study.


Journal

Acta oto-laryngologica
ISSN: 1651-2251
Titre abrégé: Acta Otolaryngol
Pays: England
ID NLM: 0370354

Informations de publication

Date de publication:
Jun 2022
Historique:
pubmed: 6 7 2022
medline: 14 7 2022
entrez: 5 7 2022
Statut: ppublish

Résumé

Non-echo planar (EPI) diffusion-weighted (DW) MRI has become an effective tool for the follow-up after cholesteatoma surgery and decreased the rate of second-look surgeries. To shed light on the optimal imaging follow-up protocol to detect postoperative residual or recurrent cholesteatoma. 64 patients were included in this prospective study. Three different surgical procedures were considered: canal-wall-up (26 patients), canal-wall-down (20 patients), and obliterative (18 patients). The imaging follow-up protocol included non-EPI DW MRI during the following postoperative periods: 1 month, 6 months, and 1, 3, 5, and 7 years after the primary surgery. MRI-positive lesions were present in 18.75% of patients. 50% of the MRI-positive findings occurred at the 1-month follow-up. The other peak of MRI positivity occurred at the 3-year follow-up. The last MRI-positive finding appeared at the 5-year follow-up. The timing for the imaging protocol proposed by this prospective study to detect recidivism after cholesteatoma surgery stressed the importance of performing non-EPI DW MRI for detecting residual, though rare, disease. Likewise, extending the follow-up to a least 5 years after primary surgery was also recommended to detect any recurrent cholesteatoma that would appear unlikely to be present beyond this time set.

Sections du résumé

BACKGROUND UNASSIGNED
Non-echo planar (EPI) diffusion-weighted (DW) MRI has become an effective tool for the follow-up after cholesteatoma surgery and decreased the rate of second-look surgeries.
OBJECTIVES UNASSIGNED
To shed light on the optimal imaging follow-up protocol to detect postoperative residual or recurrent cholesteatoma.
MATERIALS AND METHODS UNASSIGNED
64 patients were included in this prospective study. Three different surgical procedures were considered: canal-wall-up (26 patients), canal-wall-down (20 patients), and obliterative (18 patients). The imaging follow-up protocol included non-EPI DW MRI during the following postoperative periods: 1 month, 6 months, and 1, 3, 5, and 7 years after the primary surgery.
RESULTS UNASSIGNED
MRI-positive lesions were present in 18.75% of patients. 50% of the MRI-positive findings occurred at the 1-month follow-up. The other peak of MRI positivity occurred at the 3-year follow-up. The last MRI-positive finding appeared at the 5-year follow-up.
CONCLUSIONS UNASSIGNED
The timing for the imaging protocol proposed by this prospective study to detect recidivism after cholesteatoma surgery stressed the importance of performing non-EPI DW MRI for detecting residual, though rare, disease. Likewise, extending the follow-up to a least 5 years after primary surgery was also recommended to detect any recurrent cholesteatoma that would appear unlikely to be present beyond this time set.

Identifiants

pubmed: 35787729
doi: 10.1080/00016489.2022.2094464
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

484-490

Auteurs

Edoardo Covelli (E)

Department of Neuroscience, Mental Health, and Sensory Organs, Sant Andrea Hospital, Sapienza University, Rome, Italy.

Valerio Margani (V)

Department of Neuroscience, Mental Health, and Sensory Organs, Sant Andrea Hospital, Sapienza University, Rome, Italy.

Chiara Filippi (C)

Department of Neuroscience, Mental Health, and Sensory Organs, Sant Andrea Hospital, Sapienza University, Rome, Italy.

Haitham H Elfarargy (HH)

Otolaryngology Department, Kafrelsheikh University, Kafrelsheikh, Egypt.

Luigi Volpini (L)

Otolaryngology Department, Liverpool University Hospitals NHS Foundation Trust, UK.

Andrea Romano (A)

Department of Neuroradiology, Sant Andrea Hospital, Sapienza University, Rome, Italy.

Alessandro Bozzao (A)

Department of Neuroradiology, Sant Andrea Hospital, Sapienza University, Rome, Italy.

Maurizio Barbara (M)

Department of Neuroscience, Mental Health, and Sensory Organs, Sant Andrea Hospital, Sapienza University, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH